The implication of melatonin and Botulinum toxin type A in neural reconstruction and muscle repair after spinal cord injury

Yunho Jin,Yonggeun Hong
DOI: https://doi.org/10.1096/fasebj.2020.34.s1.09293
2020-04-01
The FASEB Journal
Abstract:Spinal cord is responsible for neural transmission of nerve impulses between brain and the whole body. Spinal cord injury (SCI) is caused mostly by trauma leading to motor and sensory deficits, and autonomic dysfunctions. This injury involves primary and secondary mechanisms; primary SCI is the mechanical damage to the spinal cord while secondary SCI means further prolonged insults initiated by the original damage. The therapeutic aims for SCI usually focus on the suppression of secondary SCI by means of therapeutic drugs of surgery. In this study, melatonin and Botulinum toxin type A (BTA) was exploited to accelerate the recovery of SCI. First, contribution of melatonin, which is known to have neuroprotective roles, toward the recovery from SCI through regulation of autophagy and endoplasmic reticulum (ER) stress was examined. Following SCI, muscle spasticity occurs interrupting normal functional movements. BTA was administrated to alleviate muscle spasticity for the restoration of normal movements. Melatonin was proved to protect cells from excessive autophagic cell death, and to activate ER stress response leading to the restoration of cellular homeostasis. Furthermore, dendritic branches were preserved by melatonin. Muscle degradation was suppressed following BTA injection. Furthermore, BTA injection accelerated the recovery of muscle contraction‐regulatory proteins and removal of damaged cells, and restored presynaptic homeostasis via autophagy activation. In conclusion, melatonin may result in the recovery of SCI via the regulation of autophagy and ER stress response. And, BTA was proved to draw functional recovery by alleviating muscle spasticity after SCI. In other words, melatonin or BTA could be suggested as therapeutic candidates for the recovery of SCI. National Research Foundation (NRF‐2017R1A2A2A01067169), Korea.
cell biology,biochemistry & molecular biology,biology
What problem does this paper attempt to address?